Anti-CD44 antibody [EPR1013Y] (Ab51037)

CD44, LHR, MDU2, MDU3, MIC4, CD44 antigen, CDw44, Epican, Extracellular matrix receptor III, GP90 lymphocyte homing/adhesion receptor, HUTCH-I, Heparan sulfate proteoglycan, Hermes antigen, Hyaluronate receptor, Phagocytic glycoprotein 1, Phagocytic glycoprotein I, ECMR-III, PGP-1, PGP-I

反应种属:Human
抗原名称:CD44
应用:WB, IHC

用户验证的应用

推荐稀释比例

  • IHC-P1/50 - 1/100 Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
  • WB1/5000

详细信息

免疫原The exact immunogen used to generate this antibody is proprietary information.
宿主/亚型Rabbit / IgG
抗体类型Monoclonal
全称Anti-CD44 antibody [EPR1013Y]
产品形式Liquid
储存缓冲液pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
储存条件运输条件: Conditional Ambient 推荐的短期储存时间: 1-2 weeks 推荐的短期储存条件: +4°C 推荐的长期储存条件: -20°C 储存信息: Avoid freeze / thaw cycle
纯化方式Affinity purification Protein A

背景信息

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.

文献引用 (119)

CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1.

通过 CRISPR 筛选人类胰腺癌异种移植瘤,发现 KLF5 增殖脆弱性与表观遗传修饰因子 NCAPD2 和 MTHFD1 有关。

Maeda Masahiro, Sherman Kenna, Zhou Weiqiang, Cheng Jiaqi, Nihongaki Yuta, Idrizi Adrian, Tryggvadottir Rakel, Camacho Oscar, Shang Xingbo, Min Jimin, Koldobskiy Michael A, Maitra Anirban, Levchenko Andre, Slusher Barbara S, Ji Hongkai, Feinberg Andrew P

CASC19 stabilization by ALYREF via m5C modification and its impact on SCD in colorectal cancer cell aggressiveness and stemness.

ALYREF 通过 m5C 修饰稳定 CASC19,并研究其对结直肠癌细胞侵袭性和干性中 SCD 的影响。

Zhao Li, Xie Rongjun, Li Li, Lu Xianzhou, Wang Li, Wang Hui, Liu Longfei

The lysosomal cysteine protease cathepsin L promotes stemness and multidrug resistance of non-small cell lung cancer by targeting HGF activator.

溶酶体半胱氨酸蛋白酶组织蛋白酶 L 通过靶向 HGF 激活剂促进非小细胞肺癌的干性和多药耐药性。

Shi Hui, Xu Jianyu, Wu Juan, Hu Sha, Chen Xi, Hu Qianfang, Liu Qian, Yu Yanxia, Ding Xinyuan, Wang Wenjuan

Targeted inactivation of EWSR1 : : FLI1 gene in Ewing sarcoma via CRISPR/Cas9 driven by an Ewing-specific GGAA promoter.

利用 Ewing 特异性 GGAA 启动子驱动的 CRISPR/Cas9 技术,靶向灭活 Ewing 肉瘤中的 EWSR1 : : FLI1 基因

Cervera Saint T, Martínez Selene, Iranzo-Martínez María, Notario Laura, Melero-Fernández de Mera Raquel M, Alonso Javier

Duodenal Adenocarcinoma Is Characterized by Acidity, High Infiltration of Macrophage, and Activated Linc01559-GRSF1 Axis.

十二指肠腺癌的特征是酸性、巨噬细胞高度浸润和激活的 Linc01559-GRSF1 轴

Huang Xinxin, Shi Ying, Liu Zekun, Wu Yihang, Luo Xiaotong, Chen Dongwen, Wei Zhengyu, Chen Chong, Ju Huaiqiang, Wu Xiaojian, Liu Xuanhui, Chen Zhanhong, Hu Peishan

MSC and HUVEC co-cultured fillers overcome intractable fistula in a new mouse model.

MSC 和 HUVEC 共培养的填充物在新小鼠模型中克服了顽固性瘘管

Hirasawa Soichiro, Murakami Kentaro, Kano Masayuki, Endo Satoshi, Toyozumi Takeshi, Matsumoto Yasunori, Otsuka Ryota, Sekino Nobufumi, Shiraishi Tadashi, Ryuzaki Takahiro, Kinoshita Kazuya, Sasaki Takuma, Matsubara Hisahiro

C1q-CD44 interactions regulate microglial phagocytosis, proliferation, and migration.

C1q-CD44 相互作用调节小胶质细胞的吞噬作用、增殖和迁移。

Sakthivel Pooja S, Villegas Alyssa J, Lakatos Anita, Kaipa Meghana, Lopez Julian M, Ling Ashley, Elrachid Zeina H, Karam Josh, Anderson Aileen J

Exosomes are specialized vehicles to induce fibronectin assembly.

外泌体是诱导纤连蛋白组装的特化载体

Sung Bong Hwan, Emmanuel Merlyn, Gari Metti K, Guerrero Jorge F, Virumbrales-Muñoz Maria, Inman David, Krystofiak Evan, Rapraeger Alan C, Ponik Suzanne M, Weaver Alissa M

Cellular senescence and metabolic reprogramming model based on bulk/single-cell RNA sequencing reveals PTGER4 as a therapeutic target for ccRCC

基于批量/单细胞 RNA 测序的细胞衰老和代谢重编程模型揭示 PTGER4 是 ccRCC 的治疗靶点

Lijie Zhou #, Youmiao Zeng #, Yuanhao Liu #, Kaixuan Du, Yongbo Luo, Yiheng Dai, Wenbang Pan, Lailai Zhang, Lei Zhang, Fengyan Tian, Chaohui Gu

Combination of Brucea javanica oil emulsion and Aidi injection associated with the long‑term survival of a patient with colon cancer and lung metastases post‑chemotherapy: A case report

鸦胆子油乳剂与艾迪注射液联合应用对结肠癌肺转移患者化疗后长期生存的影响:病例报道

Jiajun Song, Hailun Zhou, Chenbing Sun, Lijing Jiao, Yabin Gong, Jialin Yao, Ling Xu
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 12